The Holding Holding Company for Pharmaceuticals, Bio Farma, will soon carry out Phase 3 Clinical Trial of BUMN Vaccine to prevent Covid19 at the beginning of June 2022. The declaration was marked by a Kick-off which was held at the Faculty of Medicin...
Read moreBreaking News
-
Thursday, 19 May 2022
-
Thursday, 24 February 2022
-
Wednesday, 22 September 2021
News & Event
-
-
Bio Farma, received an award from the international community, for the novel product Oral Polio Vaccine Type 2 (nOPV2)
Read more -
The Bio-Health Fund will increase Bio Farma's capabilities in terms of innovating life science products, health tech products such as telemedicine, and so on. The ultimate goal is to form a national health ecosystem
Read more